AXON vs SPCE: Which Is the Better Buy in 2026?
Last updated August 2026
Short answer
AXON is the larger of the two ($42.54B market cap): the incumbent the market prices for continued execution (50.18x forward earnings, beta 1.38). SPCE is the smaller challenger ($327.77M), priced similarly on forward earnings (-5.67x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
AXON vs SPCE: the tie-breaker metrics
Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | AXON | SPCE | What it tells you |
|---|---|---|---|
| Market cap | $42.54B | $327.77M | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 50.18 | -5.67 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Beta | 1.38 | 2.74 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 35% of range | 6% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 12.03 | 0.93 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Before you buy: how AXON and SPCE affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. AXON and SPCE share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined AXON and SPCE exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Axon Enterprise (AXON) do?
Axon Enterprise (formerly TASER International) is the dominant supplier of body-worn cameras, in-car video, and conducted electrical weapons (TASERs) to law enforcement worldwide. The company also operates Axon Evidence (Evidence.com), the cloud-based digital evidence management platform that integrates video, audio, and case records, and Axon Records (records management system). Each Axon hardware device generates data that gets stored, processed, and analyzed in Axon's cloud platform, creating a recurring SaaS revenue stream.
What does Virgin Galactic (SPCE) do?
Virgin Galactic operates a suborbital human spaceflight business, selling tickets that carry private and research passengers briefly above the recognized boundary of space for a period of weightlessness and views of Earth. Tickets have historically been priced around ~$600,000 (as of 2026-06-27), and the company has reported a backlog of roughly 675 to 800 reserved future astronauts built up over prior sales rounds. Its closest direct peer in suborbital tourism is Blue Origin.
AXON vs SPCE: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- AXON drivers: AI-powered features; International expansion.
- SPCE drivers: Delta-class capacity; Reserved backlog and demand.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Public sector budget cycles affect short-term revenue. For SPCE, virgin Galactic generates minimal revenue today (~$0.2M in Q1 2026, as of 2026-06-27) and is burning cash heavily, with free cash flow of roughly $(93.3)M in Q1 2026 and Q2 2026 guidance of about $(87)M to $(92)M.
AXON or SPCE: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick AXON if you believe its drivers more; SPCE if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the AXON and SPCE guides.
AXON vs SPCE: the full fundamentals
AXON. Axon trades at one of the highest valuations in public sector software, reflecting the dominant position in law enforcement video and TASERs, the high-margin SaaS conversion, and the AI feature roadmap. The premium embeds high expectations and is sensitive to budget cycles.
SPCE. Traditional earnings multiples do not apply to Virgin Galactic because it is pre-revenue and deeply unprofitable; the company is valued on the speculative promise of future Delta-class flights rather than current financials. With cash burn running near or above $90M per quarter against roughly ~$251M of cash and marketable securities (as of March 31, 2026), cash runway and the pace of further capital raises are central to the story, and additional dilution is a recurring feature of how the company funds itself. Figures here are tied to the asOf date and can change quickly.
Headline figures (approximate, early 2026): AXON shows revenue (ttm) ~$2.5 billion, operating margin ~25% (non-GAAP), net income (ttm) ~$400 million (GAAP), eps (ttm) ~$5.20; SPCE shows quarterly revenue (q1 2026) ~$0.2M, essentially pre-revenue, derived from access fees on future reservations rather than completed flights, net loss (q1 2026) ~$64.7M, an improvement from a ~$84M loss in the year-ago quarter, free cash flow (q1 2026) ~$(93.3)M, with Q2 2026 guided to roughly $(87)M to $(92)M, cash and marketable securities ~$251M as of March 31, 2026, the runway funding the Delta build-out.
The bottom line: AXON vs SPCE
AXON and SPCE are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined AXON and SPCE exposure against your real portfolio. It is not an investment adviser.
Wondering how AXON or SPCE fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in Axon Enterprise with AI
Connect the broker you already use and ask Walnut's AI how AXON fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between AXON and SPCE?
+
Axon Enterprise (formerly TASER International) is the dominant supplier of body-worn cameras, in-car video, and conducted electrical weapons (TASERs) to law enforcement worldwide. Virgin Galactic operates a suborbital human spaceflight business, selling tickets that carry private and research passengers briefly above the recognized boundary of space for a period of weightlessness and views of Earth. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is AXON or SPCE the better stock?
+
Neither is universally better. AXON is the larger incumbent; SPCE is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, AXON or SPCE?
+
On forward P/E (as of August 2026), AXON trades at 50.18x and SPCE at -5.67x, so SPCE is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both AXON and SPCE?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of AXON vs SPCE?
+
AXON: Public sector budget cycles affect short-term revenue. Regulatory debates around law enforcement technology (facial recognition, predictive policing) constrain some product features. Competition from Motorola Solutions in body-worn cameras has intensified. SPCE: Virgin Galactic generates minimal revenue today (~$0.2M in Q1 2026, as of 2026-06-27) and is burning cash heavily, with free cash flow of roughly $(93.3)M in Q1 2026 and Q2 2026 guidance of about $(87)M to $(92)M. Funding that burn has meant repeated dilution, including a ~46% increase in shares outstanding over the prior year and a June 2026 debt-for-equity swap, on top of a 1-for-20 reverse split in 2024. The investment depends on flawless execution of an ambitious flight-test and manufacturing timeline that has already slipped, where any delay extends the cash drain. Spaceflight also carries inherent safety risk, and the underlying unit economics of high-frequency suborbital tourism are unproven at commercial scale.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell AXON or SPCE; figures are approximate and dated (as of August 2026). Verify current data before investing.